Germany: VIA Equity’s DMRZ acquires TTools to accelerate next phase of growth
DMRZ (Deutsches Medizinrechenzentrum), a German provider of cloud-based billing and software solutions for the healthcare sector and a portfolio company of VIA Equity, has...
France: Mérieux Equity Partners announces first close of new healthcare‑dedicated buyout fund
Mérieux Equity Partners has held a first close of its new healthcare‑dedicated buyout fund, Mérieux Participations 5 (MP5), at €335m out of a €600m...
UK: Blue Owl partners with Moor Park in acquisition of 12 acute-care hospitals operated...
US-listed alternative asset manager, Blue Owl Capital, in partnership with UK-based specialist international real estate private equity investment and asset management firm, Moor Park...
UK: G Square Healthcare PE closes £500m single-asset continuation fund for Pharmacy2U
UK-based G Square Healthcare PE has closed a £500m (US$668m) single-asset continuation fund for portfolio company Pharmacy2U, the UK’s largest online pharmacy.
The transaction, which...
US: EQT to acquire the TachoSil biosurgery business from Corza Medical
US-based PE firm, GTCR, has agreed for Corza Medical, a US-based global medtech company, to sell its Biosurgery business unit, including the TachoSil product...
UK: Clarivate announces sale of Life Sciences & Healthcare segment to Altaris for US$600m
Clarivate, a UK-based, New York-listed global provider of intelligence, has agreed to divest its Life Sciences & Healthcare segment to Altaris, a US-based investment...
Europe: CVC raises €3.0bn for Europe-focused mid-market private equity fund – Catalyst III
CVC Capital Partners has announced the final close of CVC Capital Partners Catalyst III, its European-focused mid-market private equity fund, at approximately €3.0bn (US$3.4bn)...
UK: Novartis agrees to acquire Myricx Bio for up to US$1.5bn
Swiss multinational pharma, Novartis, has agreed to acquire Myricx Bio, a UK-based biotech company developing a new class of ADCs, using N-myristoyltransferase inhibitor (NMTi)...
France: Ipsen adds to late-stage oncology pipeline with acquisition of Kartos Therapeutics
In its second major deal announcement of the week following news of its proposed acquisition of Memo Therapeutics for in excess of €700m, France...
Denmark: Impilo takes ownership of XO Care
XO Care, the Denmark-based dental unit manufacturer, has been acquired by Nordic investment company, Impilo, following the decision of Kim Sørensen, majority owner and...
Advertisement
